Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REYATAZ for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where REYATAZ was used for Maternal exposure timing unspecified.

Most Reported Side Effects for REYATAZ

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 17 12.0% 2 2
Nephrolithiasis 13 9.2% 0 3
Exposure during pregnancy 10 7.0% 0 1
Renal failure acute 10 7.0% 0 10
Jaundice 9 6.3% 0 4
Abortion spontaneous 8 5.6% 0 0
Pyrexia 7 4.9% 0 4
Stillbirth 7 4.9% 2 0
Asthenia 6 4.2% 0 6
Diarrhoea 6 4.2% 0 4
Cholestasis 5 3.5% 0 5
Drug interaction 5 3.5% 2 0
Hyperbilirubinaemia 5 3.5% 0 2
Myalgia 5 3.5% 0 5
Tendon rupture 5 3.5% 0 5

Other Indications for REYATAZ

Hiv infection (77) Antiretroviral therapy (16) Product used for unknown indication (11) Hiv test positive (5)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

REYATAZ Full Profile All Maternal exposure timing unspecified Drugs REYATAZ Demographics REYATAZ Timeline